Ledger Susan St. - May 15, 2024 Form 4 Insider Report for Klaviyo, Inc. (KVYO)

Role
Director
Signature
/s/ Landon Edmond, Attorney-in-Fact
Stock symbol
KVYO
Transactions as of
May 15, 2024
Transactions value $
-$258,930
Form type
4
Date filed
5/17/2024, 04:40 PM
Previous filing
Mar 22, 2024
Next filing
Jun 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KVYO Series A Common Stock Conversion of derivative security +10.5K 10.5K May 16, 2024 Direct F1
transaction KVYO Series A Common Stock Sale -$259K -10.5K -100% $24.66 0 May 16, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KVYO Series B Common Stock Conversion of derivative security $0 -10.5K -15% $0.00 59.5K May 15, 2024 Series A Common Stock 10.5K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into Series A Common Stock upon the occurrence of certain events set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date.
F2 These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023.
F3 Consists of (i) 12,833 shares of Series B Common Stock and (ii) 46,667 unvested restricted stock units awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement.